Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.



home / news releases / PGNX - Lantheus Holdings: PYLARIFY Approval Revitalizes My Bullish Outlook


PGNX - Lantheus Holdings: PYLARIFY Approval Revitalizes My Bullish Outlook

  • It has been nearly one year since I took a good look at Lantheus Holdings, but PYLARIFY's approval has forced me to reassess the ticker and my investment strategy.
  • PYLARIFY has the potential to be a game-changer in prostate cancer diagnosis and improve patient outcomes. The company has been hard at work preparing for launch in the USA.
  • I discuss why PYLARIFY's approval has revitalized my bullish outlook. In addition, I reveal my strategy for accumulating a larger position in LNTH.

For further details see:

Lantheus Holdings: PYLARIFY Approval Revitalizes My Bullish Outlook
Stock Information

Company Name: Progenics Pharmaceuticals Inc.
Stock Symbol: PGNX
Market: NASDAQ
Website: progenics.com

Menu

PGNX PGNX Quote PGNX Short PGNX News PGNX Articles PGNX Message Board
Get PGNX Alerts

News, Short Squeeze, Breakout and More Instantly...